Subscribe To
Vera: repurposed molecule program does not impress
Vera Therapeutics, Inc. is trying to develop an old molecule it licensed from Merck & Co., Inc. Trials ...
July 3, 2023, 1:39 pm
Eli lilly could be making the next ozempic, but should you buy the stock?
Eli Lilly is working on a molecule that might be better than Novo Nordisk's Ozempic. It already has ano...
July 2, 2023, 8:15 am
Chf 150,000 to empower biotechnologies through molecular intelligence
IsoSpec Analytics has received CHF 150,000 after winning the third stage of Venture Kick. The startup is developing a unique technology that takes the...
June 28, 2023, 2:44 pm
molecular partners to present on its radio darpin therapy (rdt) platform at snmmi 2023
RDT platform offers unique approach for tailored delivery of radioactive payloads to solid tumors RDT platform is focused on improving both tumor-targ...
June 27, 2023, 5:00 am
molecular partners to present on its radio darpin therapy (rdt) platform at snmmi 2023
RDT platform offers unique approach for tailored delivery of radioactive payloads to solid tumors RDT platform is focused on improving both tumor-targ...
June 27, 2023, 1:00 am
Biovie presents phase 3 study of alzheimer's treatment at san diego medical conference
BioVie Inc (NASDAQ:BIVI) announced that baseline data from a multicenter, randomized, placebo-controlled Phase 3 study of its Alzheimer's Disease trea...
June 26, 2023, 9:11 am
Exact sciences set to rally on positive top-line results from pivotal blue-c study
Exact Sciences (NASDAQ:EXAS) shares rose in Wednesday pre-market trading after the molecular diagnostic...
June 21, 2023, 8:14 am
Biomea fusion to present late breaking data from ongoing phase ii trial, covalent-111, evaluating bmf-219 in patients with type 2 diabetes at ada 2023
REDWOOD CITY, Calif., June 20, 2023 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage biopharmaceutical company ...
June 20, 2023, 4:30 pm
molecular partners to present at the td cowen radiopharmaceutical innovation summit
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., June 19, 2023 (GLOBE NEWSWIRE) -- molecular Partners ...
June 19, 2023, 12:00 pm
molecular templates announces debt payoff and restructuring
Restructuring agreement with K2 HealthVentures (K2HV) to fully discharge and satisfy outstanding debt owed to K2HV for the prepayment of $27.5 million...
June 17, 2023, 12:56 am
Jpmorgan ceo jamie dimon avoids more questioning over jeffrey epstein
JPMorgan didn't cut ties with Epstein until 2013 -- over a decade after he first opened accounts at the bank, and long after he was investigated for <...
June 16, 2023, 5:03 pm
Illumina ceo steps down; grail soap opera continues
And we interview Anjay Nagpal, host of the podcast "Brokers, Bagmen, and moles."...
June 16, 2023, 3:56 pm
Global supramolecular polymers market to register a staggering 6.5% cagr from 2025 to 2031, reaching us$ 453.0 million: tmr report
An Increasing focus on functional materials & coatings is a major factor that is anticipated to escalate the market growth. Increasing demand for pers...
June 15, 2023, 5:30 pm
Precipio’s omnia™ methodology enables diagnosis of mds with peripheral blood instead of bone marrow biopsy
Use of HemeScreen® technology enables diagnosis without the need for painful, invasive sampling NEW HAVEN, Conn., June 14, 2023 (GLOBE NEWSWIRE) — ...
June 14, 2023, 1:49 pm
moleculin to participate in the healthcare virtual conference presented by maxim group llc and hosted by m-vest
Live webcast fireside chat on Wednesday, June 21 st at 1:30 PM ET HOUSTON , June 13, 2023 /PRNewswire/ -- mole...
June 13, 2023, 8:35 am
Lantheus announces presentations featuring pylarify ai™ at the 2023 society for nuclear medicine and molecular imaging (snmmi) annual meeting
BEDFORD, Mass., June 12, 2023 (GLOBE NEWSWIRE) — Lantheus Holdings, Inc. (the Company) (NASDAQ: LNTH), a company committed to improving patient outc...
June 12, 2023, 12:30 pm
Immunocore holdings: unlocking the immune system's hidden potential
Immunocore Holdings is a leading biotech firm with a promising pipeline of T cell receptor-based bispecific immunotherapies for cancer, autoimmune dis...
June 11, 2023, 3:49 am
: p.f. chang’s 34-year-old ceo on what he learned from billionaire john paulson
MarketWatch recently spoke with Damola Adamolekun, one of the youngest chief executives in corporate Am...
June 10, 2023, 3:07 pm
Terns pharmaceuticals to present at goldman sachs 44th annual global healthcare conference
FOSTER CITY, Calif., June 06, 2023 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage...
June 6, 2023, 4:30 pm
Pmv pharmaceuticals to participate in the goldman sachs global healthcare conference
PRINCETON, N.J., June 06, 2023 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and...
June 6, 2023, 4:01 pm